Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03158012 · ClinicalTrials.gov registry record · Phase 1
Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients
A Phase 1 study of Atopic Dermatitis Eczema, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT03158012: Completed Phase 1 study of Atopic Dermatitis Eczema, sponsored by University of California, San Diego.
NCT03158012 is a Phase 1 study of Atopic Dermatitis Eczema that has completed, run by University of California, San Diego. The registered enrollment target is 15 participants, below the 200-participant average among 8 other Atopic Dermatitis Eczema trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03158012, a Phase 1 study of Atopic Dermatitis Eczema, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Unlike healthy control skin, the skin of patients with atopic dermatitis (AD) is frequently colonized by Staphylococcus aureus (S. aureus), putting these patients at increased risk of S. aureus skin infections. In addition, research in the investigator's lab has shown that these patients have fewer protective antimicrobial Staphylococcal species such as Staphylococcal epidermidis (S. epidermidis) that are known to produce antimicrobial peptides that play a role in protecting the skin from invading pathogens. In this study, the investigator will attempt to decrease S. aureus colonization and increase colonization of protective Staph species in AD patients. First the investigator will capture the bacteria on subjects' skin. Next the investigator will selectively grow the subject's antimicrobial Staphylococcal colonies and place them into a base moisturizer. The moisturizer plus bacteria will be applied to one of the subject's arms for one week. Some subjects will receive placebo, which is the moisturizer alone (without bacteria). The investigator will then swab the arms at specified time points during and after the one week application in order to determine whether the S. aureus abundance was affected by the application of the transplanted bacteria.
Primary Outcome
Relative abundance of S. aureus 24 hours after initial treatment application (baseline).
Conditions Studied
Interventions
- BIOLOGICAL Autologous Microbial Transplant
Study Locations (1)
California
- University of California San Diego Dermatology Clinic - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-08 |
| Phase | Phase 1 |
What the finished NCT03158012 record still lists
NCT03158012 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 200-participant average among 8 other Atopic Dermatitis Eczema trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Atopic Dermatitis Eczema appearing as the primary indexed condition, and to 1 intervention - of which Autologous Microbial Transplant is the first listed.
NCT03158012 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03158012 about?
NCT03158012 is a clinical study titled "Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients". Unlike healthy control skin, the skin of patients with atopic dermatitis (AD) is frequently colonized by Staphylococcus aureus (S. aureus), putting these patients at increased risk of S. aureus skin infections. In addition, research in the investigator's lab has shown that these patients have fewer ...
What is the current status of trial NCT03158012?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2016-04. Estimated completion is 2018-08.
What conditions does trial NCT03158012 study?
This clinical trial studies the following conditions: Atopic Dermatitis Eczema.
What interventions are being tested in trial NCT03158012?
The interventions under investigation include: Autologous Microbial Transplant (BIOLOGICAL).
Who is sponsoring clinical trial NCT03158012?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03158012 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis Eczema
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03158012's enrollment target sits among peer trials
15 9th of 8 the lowest of 8 other Atopic Dermatitis Eczema trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atopic Dermatitis Eczema trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RECRUITING · Phase 2
-
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
RECRUITING · Phase 2
-
Seal, Stopping Eczema and Allergy Study
ACTIVE NOT RECRUITING · Phase 2
-
Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children Over Time
ACTIVE NOT RECRUITING
-
Phase 2 Trial of HY209gel in Atopic Dermatitis Patients
ACTIVE NOT RECRUITING · Phase 2
-
Team-Based Connected Health (TCH) to Improve Clinical Outcomes and Access in Atopic Dermatitis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia